Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000937889-05-000001
Filing Date
2005-01-04
Accepted
2005-01-04 14:37:01
Documents
1
Period of Report
2004-12-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 13549
  Complete submission text file 0000937889-05-000001.txt   15592
Mailing Address 2950 WILDERNESS PLACE BOULDER CO 80301
Business Address 2950 WILDERNESS PLACE BOULDER CO 80301 3034496500
SIRNA THERAPEUTICS INC (Issuer) CIK: 0000892112 (see all company filings)

EIN.: 341697351 | State of Incorp.: CO | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ROOM 5508 30 ROCKEFELLER PLAZA NEW YORK NY 10112
Business Address ROOM 5508 30 ROCKEFELLER PLAZA NEW YORK NY 10112 2126495600
VENROCK ASSOCIATES (Reporting) CIK: 0000937889 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-27914 | Film No.: 05506169